Parkinsonism & related disordersHumansParkinson DiseaseMaleFemaleDementia
Association between cognitive adverse effects of anticholinergic medication and development of dementia in Parkinson's disease.
Su Hyeon Ha, Seoyeon Kim, Seungmin Lee, Bora Jin, Kyung Ah Woo, Jung Hwan Shin, Han-Joon Kim
Published: 202610.1016/j.parkreldis.2025.108136
Abstract
INTRODUCTION: Approximately one-third of patients with Parkinson's disease (PD) develop dementia, and anticholinergic use has been implicated as a risk factor, particularly with prolonged exposure. This study examined whether short-term anticholinerg…
Preview only. Read the full abstract at the source